Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST

Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
APTARGROUP, Inc. (NYSE: ATR) Delayed: 126.75 +0.20 (0.16%)
Previous Close $126.55    52 Week High $81.50 
Open $126.77    52 Week Low $66.33 
Day High $127.68    P/E 50.30 
Day Low $126.71    EPS $2.52 
Volume 28,751       

(NASDAQ: MIST) Delayed: 0.65 --0 (-0%)
Previous Close $0.65    52 Week High $ 
Open $0.65    52 Week Low $ 
Day High $0.67    P/E N/A 
Day Low $0.64    EPS $ 
Volume 310,063